Cinnamamide-chalcone derivatives as CDK2 inhibitors: synthesis, pharmacological evaluation, and molecular modelling study
- 30 July 2022
- journal article
- research article
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 19 (11) , 4445-4455
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Department of Biotechnology , Ministry of Science and Technology (F. No. BT/PR14373/Med/30/530/210)
- All India Council for Technical Education (F. No. 8-36/RIFD/RPS/Policy-1/2017-18)
- Department of Science and Technology, Ministry of Science and Technology (Funding Letter SR/FST/College-264)
This publication has 43 references indexed in Scilit:
- On the molecular mechanisms of mitotic kinase activationOpen Biology, 2012
- Apigenin: A Promising Molecule for Cancer PreventionPharmaceutical Research, 2010
- Protein kinase inhibition of clinically important staurosporine analoguesNatural Product Reports, 2010
- ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for KinasesASSAY and Drug Development Technologies, 2009
- Crystal Structure of the T315I Mutant of Abl KinaseChemical Biology & Drug Design, 2007
- LiOH·H2O as a novel dual activation catalyst for highly efficient and easy synthesis of 1,3-diaryl-2-propenones by Claisen–Schmidt condensation under mild conditionsJournal of Molecular Catalysis A: Chemical, 2006
- A new series of potent oxindole inhibitors of CDK2Bioorganic & Medicinal Chemistry Letters, 2004
- Flavonoids: Promising anticancer agentsMedicinal Research Reviews, 2003
- A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of QuiescenceJournal of Biological Chemistry, 2000
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990